Ivermectin in Adults With Severe COVID-19.

NCT04602507 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

75

Enrollment

OTHER

Sponsor class

Stopped Lack of severe COVID-19 cases in the place of study

Conditions

Covid19
Severe Acute Respiratory Syndrome

Interventions

DRUG: Ivermectin
OTHER: Placebo

Sponsor

CES University